Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
MRL Ventures Fund
company
About
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- CVC,Venture Capital
The MRL Venture Fund is the Cambridge, MA – based independent venture capital investment group within Merck Research Laboratories, the R&D division of Merck & Co., Inc. MRL Ventures creates and/or invests in seed and early-stage therapeutics companies, based on translatable breakthrough science, with the potential to deliver highly differentiated new medicines to improve human health.
Investments
Number of Investments
Number of Lead Investments
7
0
MRL Ventures Fund has made 7 investments. Their most recent investment was on
Sep 21, 2022, when Carisma Therapeutics raised $30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 21, 2022
Carisma Therapeutics
|
Series C | $30M | Biotechnology | — |
|
Mar 31, 2021
Entrada Therapeutics
|
Series B | $116M | Biotechnology | — |
|
Mar 1, 2021
Carisma Therapeutics
|
Series B | $12M | Biotechnology | — |
|
Jan 7, 2021
Carisma Therapeutics
|
Series B | $47M | Biotechnology | — |
|
Oct 6, 2019
LabCentral
|
Corporate Round | $13M | Education | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
